Functional cross-antagonism between transcription factors FLI-1 and EKLF

被引:106
|
作者
Starck, J
Cohet, N
Gonnet, C
Sarrazin, S
Doubeikovskaia, Z
Doubeikovski, A
Verger, A
Duterque-Coquillaud, M
Morle, F
机构
[1] Ctr Genet Mol & Cellular, CNRS, UMR 5534, F-69622 Villeurbanne, France
[2] Inst Biol, CNRS, UMR 8526, F-59021 Lille, France
[3] Russian Acad Sci, Inst Biochem & Physiol Microorganisms, Moscow 142292, Russia
[4] Weis Ctr Res, Danville, PA 17822 USA
关键词
D O I
10.1128/MCB.23.4.1390-1402.2003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
FLI-1 is an ETS family transcription factor which is overexpressed in Friend erythroleukemia and contributes to the blockage of differentiation of erythroleukemic cells. We show here that FLI-1 represses the transcriptional activity of the beta-globin gene promoter in MEL cells and interacts with two of its critical transactivators, GATA-1 and EKLF. Unexpectedly, FLI-1 enhances the stimulating activity of GATA-1 on a GATA-1-responsive promoter but represses that of EKLF on beta-globin and an EKLF-responsive artificial promoters. This repressive effect of FLI-1 requires the ETS DNA binding domain and its association with either the N- or C-terminal domain, which themselves interact with EKLF but not with GATA-1. Furthermore, the FLI-1 ETS domain alone behaves as an autonomous repression domain when linked to the Gal4 DNA binding domain. Taken together, these data indicate that FLI-1 represses EKLF-dependent transcription due to the repression activity of its ETS domain and its indirect recruitment to erythroid promoters by protein-protein interaction with EKLF. Reciprocally, we also show that EKLF itself represses the FLI-1-dependent megakaryocytic GPIX gene promoter, thus further suggesting that functional cross-antagonism between FLI-1 and EKLF might be involved in the control of the erythrocytic versus megakaryocytic differentiation of bipotential progenitors.
引用
收藏
页码:1390 / 1402
页数:13
相关论文
共 50 条
  • [1] The mechanism of complex formation between Fli-1 and SRF transcription factors
    Dalgleish, P
    Sharrocks, AD
    NUCLEIC ACIDS RESEARCH, 2000, 28 (02) : 560 - 569
  • [2] Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy
    Sakurai, Takuya
    Kondoh, Nobuo
    Arai, Masaaki
    Hamada, Jun-Ichi
    Yamada, Toshiyuki
    Kihara-Negishi, Fumiko
    Izawa, Tetsuya
    Ohno, Hideki
    Yamamoto, Mikio
    Oikawa, Tsuneyuki
    CANCER SCIENCE, 2007, 98 (11) : 1775 - 1784
  • [3] Fli-1 and EKLF Gene Expression in Patients with MDS 5q-Syndrome.
    Neuwirtova, Radana
    Fuchs, Ota
    Provaznikova, Dana, Jr.
    Cermak, Jaroslav
    Siskova, Magda, III
    Jonasova, Anna
    Michalova, Kyra
    BLOOD, 2009, 114 (22) : 1090 - 1091
  • [4] The miRNA cluster miR-17-92 is a direct target of the transcription factors Fli-1 and Spi-1 acting downstream of Fli-1 in Friend Erythroleukemia
    Kayali, Samer
    Guyot, Boris
    Morle, Francois
    BULLETIN DU CANCER, 2011, 98 : S49 - S50
  • [5] Fli-1, a Functional Factor Performed in Autoimmune Lupus
    Wang-Dong Xu
    Min Zhang
    Yi Zhao
    Yi Liu
    Inflammation, 2016, 39 : 493 - 498
  • [6] The ets transcription factor Fli-1 in development, cancer and disease
    Li, Y.
    Luo, H.
    Liu, T.
    Zacksenhaus, E.
    Ben-David, Y.
    ONCOGENE, 2015, 34 (16) : 2022 - 2031
  • [7] Fli-1, a Functional Factor Performed in Autoimmune Lupus
    Xu, Wang-Dong
    Zhang, Min
    Zhao, Yi
    Liu, Yi
    INFLAMMATION, 2016, 39 (01) : 493 - 498
  • [8] The ets transcription factor Fli-1 in development, cancer and disease
    Y Li
    H Luo
    T Liu
    E Zacksenhaus
    Y Ben-David
    Oncogene, 2015, 34 : 2022 - 2031
  • [9] Fgf differentially controls cross-antagonism between cardiac and haemangioblast regulators
    Simoes, Filipa Costa
    Peterkin, Tessa
    Patient, Roger
    DEVELOPMENT, 2011, 138 (15): : 3235 - 3245
  • [10] Functional interference between retinoic acid or steroid hormone receptors and the oncoprotein Fli-1
    Thomas G Darby
    Joachim D Meißner
    Andreas Rühlmann
    Walter H Mueller
    Renate J Scheibe
    Oncogene, 1997, 15 : 3067 - 3082